Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time
February 13, 2020 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund
February 07, 2020 16:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon Enters into a Distribution Agreement for Qatar
December 18, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable,...
Obalon To Present at Two Upcoming Institutional Investor Conferences
November 14, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company focused on commercializing the Obalon Balloon System, the first and...
Obalon Announces Third Quarter 2019 Financial Results
November 08, 2019 07:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Clinical Data Set to be Featured During the 36th ASMBS Annual Meeting at Obesity Week 2019
November 05, 2019 05:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time
October 31, 2019 07:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer
October 24, 2019 08:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a San Diego-based weight loss solutions company focused on commercializing the Obalon Balloon System, the first...
Obalon Announces First Patient Treatments at its First Company-Owned Center for Weight Loss
October 22, 2019 08:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intra-gastric...
Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement
October 03, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a San Diego-based company focused on commercializing the Obalon Balloon System, the first and only FDA-approved...